Key Takeaways
- Value-Based Insurance Design (VBID) aligns member cost-sharing with the clinical value of services — reducing barriers to high-value care while maintaining cost-sharing signals for low-value or discretionary services.
- The core VBID principle: cost-sharing should be inversely proportional to clinical value. High-value services (preventive care, chronic disease medications) have low or zero cost-sharing; low-value services have higher cost-sharing.
- VBID for chronic disease medications — eliminating copays for diabetes, hypertension, and heart failure drugs — consistently shows positive ROI through reductions in hospitalizations and ER visits.
- VBID can also be used to steer members toward high-value providers — lower cost-sharing at COEs, high-performing physician groups, and direct primary care practices.
- VBID requires claims data to identify which services and providers are high-value for your specific population — it is not a one-size-fits-all plan design.
The VBID Framework
Traditional health plan design applies uniform cost-sharing across all services — the same deductible and coinsurance regardless of whether the service is a high-value preventive intervention or a low-value discretionary procedure. This blunt approach creates two problems: it deters members from seeking high-value care that prevents expensive downstream events, and it fails to create meaningful cost-sharing signals for low-value services.
Value-Based Insurance Design, developed by Dr. A. Mark Fendrick at the University of Michigan, addresses both problems by making cost-sharing a function of clinical value rather than service category. The framework asks a simple question for every covered service: does this service prevent expensive downstream events, improve outcomes for members who need it, or reduce total episode cost? If yes, reduce or eliminate cost-sharing. If no, maintain or increase cost-sharing.
The VBID insight that changed employer plan design: a $20 copay for a statin prescription costs the plan $20 in foregone cost-sharing. But if that $20 copay causes a member to skip their medication, the resulting cardiovascular event costs the plan $50,000 or more. The copay is not saving money — it is creating a false economy that generates far larger downstream costs.
VBID for Chronic Disease Medications
The most well-studied and highest-ROI application of VBID is eliminating or reducing cost-sharing for chronic disease medications. The evidence is consistent across multiple studies and populations:
| Condition | VBID Intervention | Adherence Impact | Downstream Savings |
|---|---|---|---|
| Diabetes | Zero copay for insulin, metformin, GLP-1s | +15–25% adherence | 10–20% reduction in diabetes hospitalizations |
| Hypertension | Zero copay for ACE inhibitors, ARBs, beta-blockers | +10–20% adherence | 8–15% reduction in cardiovascular events |
| Heart failure | Zero copay for ACE inhibitors, beta-blockers, diuretics | +15–20% adherence | 15–25% reduction in heart failure readmissions |
| Asthma/COPD | Zero copay for controller medications | +10–20% adherence | 20–30% reduction in ER visits and hospitalizations |
| Depression | Zero copay for antidepressants | +10–15% adherence | Reduced absenteeism and disability claims |
Start with the conditions that are most prevalent and most costly in your population. If diabetes is your top cost driver, a zero-copay diabetes medication program is the highest-ROI VBID intervention. Use your claims data to identify the conditions where adherence-sensitive hospitalizations are most frequent — those are your VBID targets.
VBID for Provider Steerage
VBID can also be applied to provider selection — using differential cost-sharing to steer members toward high-value providers and away from low-value or high-cost providers.
- Tiered networks: Assign providers to tiers based on quality and cost efficiency. Members pay lower cost-sharing for Tier 1 (high-value) providers and higher cost-sharing for Tier 2 or Tier 3 providers.
- COE steerage: Waive member cost-sharing for procedures performed at designated Centers of Excellence — creating a strong financial incentive to use the highest-quality providers for complex procedures.
- Direct Primary Care integration: Waive or reduce cost-sharing for members who use a DPC practice as their primary care home — incentivizing the care model that generates the best primary care outcomes.
- High-performance networks: Some employers create a high-performance network of providers who meet quality and efficiency standards — with significantly lower cost-sharing than the standard network.
- Site-of-care steerage: Apply lower cost-sharing for services performed in lower-cost settings — outpatient surgery centers versus hospital outpatient departments, retail clinics versus urgent care centers versus ERs.
VBID for Low-Value Care Reduction
The other side of VBID is using higher cost-sharing to reduce utilization of low-value services — procedures and tests that provide little or no clinical benefit for most patients.
- Choosing Wisely: The ABIM Foundation's Choosing Wisely initiative has identified hundreds of tests and procedures that are commonly overused and provide little clinical benefit. These are candidates for higher cost-sharing under a VBID framework.
- Imaging steerage: Routine imaging (MRI, CT) for low back pain without red flags is a common low-value service. Requiring a primary care visit before imaging approval reduces unnecessary imaging.
- ER steerage: Higher cost-sharing for non-emergency ER visits — combined with lower cost-sharing for urgent care and telehealth — steers members to appropriate care settings.
- Brand-to-generic steerage: Higher cost-sharing for brand-name drugs when a generic equivalent is available — a standard VBID tool that is already widely implemented.
Implementing VBID: A Practical Roadmap
VBID implementation is a multi-year journey, not a single plan design change. A practical roadmap:
- 1Year 1 — Foundation: Implement zero cost-sharing for preventive care (ACA-required) and generic chronic disease medications for your top 2 to 3 conditions. Measure adherence rates and downstream claims at 12 months.
- 2Year 2 — Provider steerage: Implement tiered network cost-sharing or COE steerage for your highest-cost procedure categories. Measure COE utilization and episode cost at 12 months.
- 3Year 3 — Low-value care: Implement higher cost-sharing for identified low-value services — non-emergency ER visits, brand-name drugs with generic equivalents, unnecessary imaging. Measure utilization changes.
- 4Ongoing — Refinement: Use claims data to evaluate the impact of each VBID element and refine the design annually. Add new high-value interventions as evidence accumulates.
VBID plan design changes must be documented in the plan document and SPD and communicated to members before the plan year begins. Changes that reduce benefits mid-year require a special enrollment period. Work with ERISA counsel to ensure all VBID changes are properly documented and communicated.
Your Action Steps
- 1Pull your top 5 chronic conditions by total plan spend and calculate the adherence rate (PDC) for each condition's key medications — identify the adherence gap.
- 2Model the financial impact of eliminating copays for your top chronic disease condition — estimate the adherence improvement and resulting reduction in hospitalizations.
- 3Review your current cost-sharing structure for preventive care — confirm all USPSTF A/B-rated services are covered with zero cost-sharing as required by the ACA.
- 4Identify your highest-cost procedure categories and evaluate whether COE steerage with waived cost-sharing is feasible for any of them.
- 5Review your ER utilization data — what percentage of ER visits are for non-emergency conditions? Model the impact of a higher ER cost-sharing tier with a lower urgent care tier.
- 6Draft a 3-year VBID roadmap with specific interventions, measurement metrics, and target ROI for each plan year.
Knowledge Check
5 questions · passing score 4/5
Test your understanding of this module. You need 4 out of 5 correct to pass. You can retake the quiz as many times as you like.